<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33821250</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-6340</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>Med (New York, N.Y.)</Title><ISOAbbreviation>Med</ISOAbbreviation></Journal><ArticleTitle>Alterations in T and B cell function persist in convalescent COVID-19 patients.</ArticleTitle><Pagination><StartPage>720</StartPage><EndPage>735.e4</EndPage><MedlinePgn>720-735.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medj.2021.03.013</ELocationID><Abstract><AbstractText Label="BACKGROUND">Emerging studies indicate that some coronavirus disease 2019 (COVID-19) patients suffer from persistent symptoms, including breathlessness and chronic fatigue; however, the long-term immune response in these patients presently remains ill-defined.</AbstractText><AbstractText Label="METHODS">Here, we describe the phenotypic and functional characteristics of B and T&#xa0;cells in hospitalized COVID-19 patients during acute disease and at 3-6&#xa0;months of convalescence.</AbstractText><AbstractText Label="FINDINGS">We report that the alterations in B cell subsets observed in acute COVID-19 patients were largely recovered in convalescent patients. In contrast, T&#xa0;cells from convalescent patients displayed continued alterations with persistence of a cytotoxic program evident in CD8<sup>+</sup> T&#xa0;cells as well as elevated production of type 1 cytokines and interleukin-17 (IL-17). Interestingly, B cells from patients with acute COVID-19 displayed an IL-6/IL-10 cytokine imbalance in response to Toll-like receptor activation, skewed toward a pro-inflammatory phenotype. Whereas the frequency of IL-6<sup>+</sup> B cells was restored in convalescent patients irrespective of clinical outcome, the recovery of IL-10<sup>+</sup> B cells was associated with the resolution of lung pathology.</AbstractText><AbstractText Label="CONCLUSIONS">Our data detail lymphocyte alterations in previously hospitalized COVID-19 patients up to 6&#xa0;months following hospital discharge and identify 3 subgroups of convalescent patients based on distinct lymphocyte phenotypes, with 1 subgroup associated with poorer clinical outcome. We propose that alterations in B and T&#xa0;cell function following hospitalization with COVID-19 could affect longer-term immunity and contribute to some persistent symptoms observed in convalescent COVID-19 patients.</AbstractText><AbstractText Label="FUNDING">Provided by UKRI, Lister Institute of Preventative Medicine, the Wellcome Trust, The Kennedy Trust for Rheumatology Research, and 3M Global Giving.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shuwa</LastName><ForeName>Halima A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Tovah N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, Edinburgh EH9 3FL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Sean B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wemyss</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClure</LastName><ForeName>Flora A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearmain</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wellcome Trust Centre for Cell Matrix Research, The University of Manchester, Manchester M13 9PT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection, Immunity, and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prise</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagger</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maternal and Fetal Health Centre, Division of Developmental Biology, School of Medical Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, 5th Floor, St. Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ustianowski</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regional Infectious Diseases Unit, North Manchester General Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakerly</LastName><ForeName>Nawar Diar</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dark</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity, and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Department, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brightling</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester LE3 9QP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brij</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CIRCO</CollectiveName></Author><Author ValidYN="Y"><LastName>Felton</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity, and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity, and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grainger</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussell</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konkel</LastName><ForeName>Joanne E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>Madhvi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity, and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Room 2.16, Core Technology Facility, 46 Grafton Street, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>21927</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L011840/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V028448/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BB/M025977/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BB/S01103X/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>202865/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med</MedlineTA><NlmUniqueID>101769215</NlmUniqueID><ISSNLinking>2666-6340</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">convalescent patients</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">viral Infection</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Rohan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avery</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Birchall</LastName><ForeName>Katharine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charsley</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chenery</LastName><ForeName>Alistair</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chew</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connolly</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connolly</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dawson</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Durrans</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Durrington</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Egan</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Filbey</LastName><ForeName>Kara</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francis</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franklin</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glasgow</LastName><ForeName>Susannah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godfrey</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gray</LastName><ForeName>Kathryn J</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grundy</LastName><ForeName>Seamus</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerin</LastName><ForeName>Jacinta</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hackney</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayes</LastName><ForeName>Chantelle</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hardy</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Jade</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>John</LastName><ForeName>Anu</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jolly</LastName><ForeName>Bethany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>K&#xe4;stele</LastName><ForeName>Verena</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerry</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lui</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lin</LastName><ForeName>Lijing</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathioudakis</LastName><ForeName>Alex G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moizer</LastName><ForeName>Clare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Katrina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moss</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Syed Murtuza</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliver</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padden</LastName><ForeName>Grace</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parkinson</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phuycharoen</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saha</LastName><ForeName>Ananya</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salcman</LastName><ForeName>Barbora</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>Nicholas A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Seema</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shepley</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Lara</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephan</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephens</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tavernier</LastName><ForeName>Gael</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tudge</LastName><ForeName>Rhys</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wareing</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warren</LastName><ForeName>Roanna</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willmore</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Younas</LastName><ForeName>Mehwish</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>6</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33821250</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pii">S2666-6340(21)00115-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Ni Z.-Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., China Medical Treatment Expert Group for Covid-19 Clinical&#xa0;Characteristics of Coronavirus Disease 2019 in China. N.&#xa0;Engl. J. Med. 2020;382:1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri-Cervantes L., Pampena M.B., Meng W., Rosenfeld A.M., Ittner C.A.G., Weisman A.R., Agyekum R.S., Mathew D., Baxter A.E., Vella L.A. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 2020;5:eabd7114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., Yale IMPACT Team Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann E.R., Menon M., Knight S.B., Konkel J.E., Jagger C., Shaw T.N., Krishnan S., Rattray M., Ustianowski A., Bakerly N.D., NIHR Respiratory TRC. CIRCO Longitudinal immune profiling reveals key&#xa0;myeloid signatures associated with COVID-19. Sci. Immunol. 2020;5:eabd6197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857390</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D., Giles J.R., Baxter A.E., Oldridge D.A., Greenplate A.R., Wu J.E., Alanio C., Kuri-Cervantes L., Pampena M.B., D&#x2019;Andrea K., UPenn COVID&#xa0;Processing Unit Deep immune&#xa0;profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369:eabc8511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk A.J., Rustagi A., Zhao N.Q., Roque J., Mart&#xed;nez-Col&#xf3;n G.J., McKechnie J.L., Ivison G.T., Ranganath T., Vergara R., Hollis T. A single-cell atlas of the peripheral immune response in patients with&#xa0;severe COVID-19. Nat. Med. 2020;26:1070&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H. Clinical and immunological features of severe and moderate coronavirus disease 2019. J.&#xa0;Clin. Invest. 2020;130:2620&#x2013;2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser E. Long term respiratory complications of covid-19. BMJ. 2020;370:m3001.</Citation><ArticleIdList><ArticleId IdType="pubmed">32747332</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams F.M.K., Muirhead N., Pariante C. Covid-19 and chronic fatigue. BMJ. 2020;370:m2922.</Citation><ArticleIdList><ArticleId IdType="pubmed">32732337</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodda L.B., Netland J., Shehata L., Pruner K.B., Morawski P.A., Thouvenel C.D., Takehara K.K., Eggenberger J., Hemann E.A., Waterman H.R. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169&#x2013;183.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682481</ArticleId><ArticleId IdType="pubmed">33296701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., Grifoni A., Ramirez S.I., Haupt S., Frazier A. Immunological memory to SARS-CoV-2 assessed for up to 8&#xa0;months after infection. Science. 2021;371:eabf4063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Mentzer A.J., Liu G., Yao X., Yin Z., Dong D., Dejnirattisai W., Rostron T., Supasa P., Liu C., Oxford Immunology Network Covid-19 Response T&#xa0;cell Consortium. ISARIC4C Investigators Broad and strong memory CD4+ and CD8+ T&#xa0;cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 2020;21:1336&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611020</ArticleId><ArticleId IdType="pubmed">32887977</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradenas E., Trinit&#xe9; B., Urrea V., Marfil S., &#xc1;vila-Nieto C., Rodr&#xed;guez de la Concepci&#xf3;n M.L., Tarr&#xe9;s-Freixas F., P&#xe9;rez-Yanes S., Rovirosa C., Ainsua-Enrich E. Stable neutralizing antibody levels 6&#xa0;months after mild and severe COVID-19 episode. Med (N Y) 2021;2:313&#x2013;320.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847406</ArticleId><ArticleId IdType="pubmed">33554155</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann A., Foucat E., Hocini H., Lefebvre C., Hejblum B.P., Durand M., Kr&#xfc;ger M., Keita A.K., Ayouba A., M&#xe9;ly S., PostEboGui Study Group Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat. Commun. 2020;11:3730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381622</ArticleId><ArticleId IdType="pubmed">32709840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.-S., Oshansky C.M., Guo X.J., Ralston J., Wood T., Seeds R., Newbern C., Waite B., Reynolds G., Widdowson M.A., SHIVERS Investigation Team Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study. J.&#xa0;Infect. Dis. 2018;217:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335675</ArticleId><ArticleId IdType="pubmed">29112724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H., Zeng W., He H., Zhao D., Jiang D., Zhou P., Cheng L., Li Y., Ma X., Jin T. Serum IgA, IgM, and IgG responses in COVID-19. Cell. Mol. Immunol. 2020;17:773&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331804</ArticleId><ArticleId IdType="pubmed">32467617</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q.-X., Liu B.-Z., Deng H.-J., Wu G.C., Deng K., Chen Y.K., Liao P., Qiu J.F., Lin Y., Cai X.F. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 2020;26:845&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H.Q., Sun B.Q., Fang Z.F., Zhao J.C., Liu X.Y., Li Y.M., Sun X.Z., Liang H.F., Zhong B., Huang Z.F. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur. Respir. J. 2020;56:2001526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236821</ArticleId><ArticleId IdType="pubmed">32398307</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A.G., Lorenc A., Del Molino Del Barrio I., Das A., Fish M., Monin L., Mu&#xf1;oz-Ruiz M., McKenzie D.R., Hayday T.S., Francos-Quijorna I. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 2020;26:1623&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., P&#xe9;r&#xe9; H., Charbit B., Bondet V., Chenevier-Gobeaux C. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., John Wherry E. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 2020;20:529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevarajan I., Nguyen T.H.O., Koutsakos M., Druce J., Caly L., van de Sandt C.E., Jia X., Nicholson S., Catton M., Cowie B. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat. Med. 2020;26:453&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095036</ArticleId><ArticleId IdType="pubmed">32284614</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Dai T., Zhou X., Qian H., Guo R., Lei L., Zhang X., Zhang D., Shi L., Cheng Y. Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2. medRxiv. 2020 doi: 10.1101/2020.03.23.20040675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.23.20040675</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderbacher C.R., Ramirez S.I., Dan J.M., Grifoni A., Hastie K.M., Weiskopf D., Belanger S., Abbott R.K., Kim C., Choi J. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996&#x2013;1012.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Brainard D.M., Tager A.M., Misdraji J., Frahm N., Lichterfeld M., Draenert R., Brander C., Walker B.D., Luster A.D. Decreased CXCR3+ CD8 T&#xa0;cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction. J.&#xa0;Virol. 2007;81:8439&#x2013;8450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951383</ArticleId><ArticleId IdType="pubmed">17553894</ArticleId></ArticleIdList></Reference><Reference><Citation>Henneken M., D&#xf6;rner T., Burmester G.-R., Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res. Ther. 2005;7:R1001&#x2013;R1013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1257429</ArticleId><ArticleId IdType="pubmed">16207316</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser B. CXCR5, the Defining Marker for Follicular B Helper T (TFH) Cells. Front. Immunol. 2015;6:296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4459225</ArticleId><ArticleId IdType="pubmed">26106395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T., Perez-Potti A., Rivera-Ballesteros O., Str&#xe5;lin K., Gorin J.-B., Olsson A., Llewellyn-Lacey S., Kamal H., Bogdanovic G., Muschiol S. Robust T&#xa0;cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183:158&#x2013;168.e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., Meschiari M., Gibellini L., Bellinazzi C., Borella R., Fidanza L., Gozzi L., Iannone A., Lo Tartaro D., Mattioli M. Marked T&#xa0;cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 2020;11:3434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.S. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidleman J., Luo X., Frouard J., Xie G., Gill G., Stein E.S., McGregor M., Ma T., George A.F., Kosters A. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential. Cell Rep. Med. 2020;1:100081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437502</ArticleId><ArticleId IdType="pubmed">32839763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H.-Y., Zhang M., Yang C.-X., Zhang N., Wang X.C., Yang X.P., Dong X.Q., Zheng Y.T. Elevated exhaustion levels and reduced functional diversity of T&#xa0;cells in peripheral blood may predict&#xa0;severe progression in COVID-19&#xa0;patients. Cell. Mol. Immunol. 2020;17:541&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091621</ArticleId><ArticleId IdType="pubmed">32203186</ArticleId></ArticleIdList></Reference><Reference><Citation>Compeer E.B., Uhl L.F.K. Antibody response to SARS-CoV-2 &#x2014; sustained after all? Nat. Rev. Immunol. 2020;20:590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418089</ArticleId><ArticleId IdType="pubmed">32782353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L., Ye F., Cheng M.-L., Feng Y., Deng Y.Q., Zhao H., Wei P., Ge J., Gou M., Li X. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. 2020;52:971&#x2013;977.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196424</ArticleId><ArticleId IdType="pubmed">32413330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonn T., Corman V.M., Johnsen M., Richter A., Rodionov R.N., Drosten C., Bornstein S.R. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma. Lancet Microbe. 2020;1:e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279746</ArticleId><ArticleId IdType="pubmed">32835332</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita T. Regulatory and effector B cells: friends or foes? J.&#xa0;Dermatol. Sci. 2019;93:2&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30514664</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair P.A., Nore&#xf1;a L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally&#xa0;impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32:129&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">20079667</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Borja F., Bosma A., Ng D., Reddy V., Ehrenstein M.R., Isenberg D.A., Mauri C. CD19+CD24hiCD38hi B cells maintain regulatory T&#xa0;cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 2013;5:173ra23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23427243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri C., Menon M. Human regulatory B cells in health and disease: therapeutic potential. J.&#xa0;Clin. Invest. 2017;127:772&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5330739</ArticleId><ArticleId IdType="pubmed">28248202</ArticleId></ArticleIdList></Reference><Reference><Citation>Metsalu T., Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43(W1):W566&#x2013;W570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4489295</ArticleId><ArticleId IdType="pubmed">25969447</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>